
zzso targeted therapies have emerged as the leading theme in cancer zzso zzso drug regimens have been highly successful, yet many studies in targeted zzso have centered on a single zzso We investigated whether the zzso zzso inhibitor zzso displays zzso with other agents in zzso zzso breast cancer cell zzso zzso zzso and zzso display different signaling and gene signatures profiles due to expression of the zzso zzso zzso or zzso Cell proliferation was measured following treatment with zzso zzso zzso or zzso targeted agents zzso zzso zzso pan zzso inhibitor zzso and zzso inhibitor zzso zzso for single or combination drugs were calculated and analyzed by the zzso zzso The drugs with the greatest level of zzso with zzso were zzso zzso and zzso for the zzso zzso and zzso cell lines zzso However, zzso zzso with both zzso and zzso targeted agents in all three zzso zzso breast cancer cell zzso These results suggest that effectiveness of rationally designed therapies may not entirely rest on precise identification of gene signatures or molecular zzso Since a systems analysis that reveals emergent properties cannot be easily performed for each cancer case, zzso regimens in the near future will still involve empirical zzso 

